CASA’s Addiction Speaker Series

Addiction Speaker Series pic

Addiction Speaker Series
Image: centeronaddiction.org

Mitchell Blutt, MD, is CEO and founder of Consonance Capital , a healthcare investment firm based in New York City. Dr. Mitchell Blutt also serves as a clinical assistant professor at Weill Cornell Medical College and is a former member of the advisory board for CASA, The National Center on Addiction and Substance Abuse.

CASA, founded in 1992, strives to “connect science with policy and practice” in the field of addiction and substance abuse, with the ultimate goal of improving the lives of those afflicted both directly and indirectly by this destructive illness.

To date, CASA researchers have published more than 200 articles on substance abuse and addiction. In addition, the organization is dedicated to keeping the public informed on the importance of preventing substance use by children, and the misunderstood nature of addiction, which is often seen as a choice rather than an illness. CASA also highlights nationwide shortcomings such as the mere two cents of every dollar of federal spending received each year for addiction prevention and treatment.

The organization’s Addiction Speaker Series brings in experts whose talks on topics as diverse as “Digital Interventions to Reduce Problem Substance Use” and “Adolescent Substance Misuse Prevention” are available both live at CASA’s New York office, and as webinars. The series is free but the live events require registration.

Advertisements

Penn Names Francis E. Johnston Endowed Term Professor

 Francis E. Johnston pic

Francis E. Johnston
Image: ldi.upenn.edu

A respected voice in the health care investment sector, Mitchell Blutt, MD, serves as chief executive officer of Consonance Capital in New York City. An alumnus of the University of Pennsylvania, Mitchell Blutt, MD, serves on the Board of Overseers for the college’s School of Arts and Sciences.

The University of Pennsylvania’s School of Arts and Sciences recently announced that Harold L. Dibble will serve as the school’s Francis E. Johnston Endowed Term Professor. An anthropology professor at the school, Dibble is also the main curator for the Penn Museum’s European archaeology area and has previously served on the museum’s Laboratory Committee, along with other key positions during his career at Penn.

A leading anthropological researcher, Dibble specializes in Paleolithic human origin studies focused on North Africa and Western Europe. In his research work, he leads two high-profile archaeological digs in the Pech de l’Azé IV and La Ferrassie areas of France.

New Parkinson’s Disease Research Maps Out Inhibitory Processes

Neurotransmission pic

Neurotransmission
Image: oist.jp

As CEO of Consonance Capital, Dr. Mitchell Blutt guides private equity funds and health care investments. Community focused, Dr. Mitchell Blutt supports a number of nonprofits and is a past board member of the Michael J. Fox Foundation, which is working to find a cure for Parkinson’s disease.

Impacting 10 million people across the globe, Parkinson’s disease is a neurological condition that results in deterioration of physical function, with uncontrollable tremors leading to nerve cells misfiring and dying within the brain. Still incurable, Parkinson’s disease is not fully understood by medical researchers.

A recently published study by the Okinawa Institute of Science and Technology Graduate University revealed the protein that blocks the proper transmission of neural signals that underpin higher brain functioning. Neurotransmission enables neurons to communicate signals effectively and transfer them in ways that allow seamless sensory motor functioning.

The chemical messengers contained in vesicle endocytosis within the nerve terminal are essential in transmitting neurological signals. When the process of endocytosis is inhibited during times of heavy use, processes breakdown and sensory perception of motor control is affected. Understanding this inhibitory process promises to offer a vital step toward tailoring treatments to actual neurological conditions in ways that have a positive for among patients.

Urban Health Research at the New York Academy of Medicine

Institute for Urban Health pic

Institute for Urban Health
Image: nyam.org

A health care executive based in New York City, Dr. Mitchell Blutt serves as the chief executive officer of Consonance Capital. Dr. Mitchell Blutt is also a member of the New York Academy of Medicine, a nonprofit organization dedicated to improving the overall health of people living in urban settings.

The New York Academy of Medicine hosts the Institute for Urban Health, a policy organization designed to create innovative solutions to health issues in cities. The Institute for Urban Health takes a collaborative, interdisciplinary approach to improving urban health. In particular, the Institute focuses on matters such as increasing preventive care and healthy aging and eliminating health disparities.

To accomplish its mission, the Institute for Urban Health conducts a variety of studies using quantitative and qualitative research. The organization partners chiefly with health care systems and health departments across New York City, as well as local universities and community organizations. The Institute for Urban Health performs its research through units such as the Center for Health Innovation, which focuses on the most important determinants of health on a broad scale.